Related Experiment Video
Updated: Mar 31, 2026

Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples
Published on: May 19, 2020
Heterogeneity in longitudinal medication adherence patterns among patients with spinal tuberculosis: a latent class
Na Wang1, Haijing Xiao2, Yujuan Liu3
1The Second Department of Orthopaedic Trauma, General Hospital of Ningxia Medical University, Yinchuan, China.
Objective:
This study aims to explore the dynamic trajectory of medication adherence behavior and its influencing factors among patients with spinal tuberculosis within 6 months after discharge, providing a basis for developing individualized intervention strategies.
Methods:
A retrospective analysis was conducted using data from a longitudinal follow-up cohort, enrolling 117 spinal tuberculosis patients who underwent surgical treatment at the General Hospital of Ningxia Medical University between January 2024 and August 2025. Data were collected via telephone follow-up at 1 week, 1 month, 3 months, and 6 months after discharge, including general demographic information, scores from the Morisky Medication Adherence Questionnaire, Oswestry Disability Index (ODI), and laboratory indicators such as erythrocyte sedimentation rate and C-reactive protein levels. Group-based trajectory modeling (GBTM) was employed to identify subgroups of medication adherence trajectories, and multivariate logistic regression analysis was conducted to examine the influencing factors of these trajectory patterns.
Results:
Among 117 patients, group-based trajectory modeling identified three medication adherence trajectories: "persistently high adherence" (35.0%, n = 41), "fluctuating decline" (48.7%, n = 57), and "early low adherence" (16.2%, n = 19). The early low adherence group was older (64.21 ± 5.92 years) and had higher baseline ODI (62.11 ± 5.15) and CRP (39.58 ± 12.40 mg/L). Factors associated with non-adherence in the fluctuating vs. high adherence group included higher ODI z-score (OR = 4.658, 95% CI: 3.851-5.581), adverse drug reactions (OR = 3.249, 95% CI: 2.664-3.868), older age z-score (OR = 1.974, 95% CI: 1.524-2.516), and higher log(CRP+1) (OR = 1.532, 95% CI: 1.314-1.776). Protective factors were family supervision (OR = 0.779, 95% CI: 0.633-0.943), higher education (OR = 0.576, 95% CI: 0.498-0.660), and higher monthly income z-score (OR = 0.471, 95% CI: 0.373-0.583). All analyses were based on 1,000 bootstrap samples with L2 regularization.
Conclusions:
Medication adherence behavior among spinal tuberculosis patients exhibits heterogeneous dynamic trajectories. Clinically, tailored interventions should be developed according to the characteristics and influencing factors of different trajectory subgroups, with particular attention to older patients, those with lower educational levels, those experiencing adverse drug reactions, and those lacking supervision, in order to improve medication adherence.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Drug Therapy
Antianxiety Medications
Dosage Regimen: Individualization
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:

